妊娠高血壓疾病陳曉軍_第1頁(yè)
妊娠高血壓疾病陳曉軍_第2頁(yè)
妊娠高血壓疾病陳曉軍_第3頁(yè)
妊娠高血壓疾病陳曉軍_第4頁(yè)
妊娠高血壓疾病陳曉軍_第5頁(yè)
已閱讀5頁(yè),還剩49頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

妊娠高血壓疾病陳曉軍第1頁(yè)/共54頁(yè)HypertensiveDisorderscomplicatingPregnancyGestationalHypertensionPreeclampsiaPreeclampsiaSuperimposedonChronicHypertensionChronicHypertensionEclampsiaAGroupofRelatedDiseases第2頁(yè)/共54頁(yè)CharacteristicsSystemicsmallarteriesspasmEndothelialcellinjuryHypertensionProteinuriaMultipleorgansdysfunctionConvulsionMaternalmortalityFetalmortalityGestationalHypertension;ChronichypertensionEclampsiaPreeclampsia;PreeclampsiaSuperimposedonChronicHypertension第3頁(yè)/共54頁(yè)HypertensiondisorderscomplicatingpregnancyPathophysiologyCategoryandclinicalmanifestationDiagnosisanddifferentialdiagnosisManagementandprevention病理生理臨床表現(xiàn)診斷治療第4頁(yè)/共54頁(yè)EpidemiologyIncidence:6-9%Preeclampsia-eclampsia:

70%ChronicHypertension:

30%Eclampsia 0.5%-1%China1.0%Overseas0.5%ReflectionofmedicallevelThesecondcauseofmaternaldeath(20%)Causeofprematuredelivery(10%)Unknownorigin第5頁(yè)/共54頁(yè)P(yáng)athophysiologyBasicpathologicalchangesSpasmofsystemicsmallarteriesVascularendothelialcell

injury第6頁(yè)/共54頁(yè)P(yáng)athophysiologyfluidproteinHypertensionEdemaProteinuriaHemoconcentrationSmallarterialspasmEndothelialcellinjuryMultipleorgansdysfunctionIschemiaEdemamalfunction第7頁(yè)/共54頁(yè)SystemicDisease第8頁(yè)/共54頁(yè)BrainHydrocephalusHyperemia/ischemiaThrombosiscerebralhemorrhagecerebralherniaheadachedazzlenauseavomitHypopsiaretinaldetachmentCorticalblindnessDysesthesiaConfusionofthinkingEclampsiaconvulsioncomabrain:Vasospasmpermeability↑第9頁(yè)/共54頁(yè)kidneyrenalvasospasmrenalbloodflow↓glomerularfiltrationrate↓pathology:Glomerularexpansionswollenvascularendothelialcellcellulosedepositionrenocorticalnecrosis——renalirreversibledamageclinicalmanifestation:albuminuriahypoproteinemiarenaldysfunctioncreatinineureanitrogenuricacidoliguriarenalfailure第10頁(yè)/共54頁(yè)liverhepaticvasospasm;hepaticischemia;hepaticedemaliverenlargement;hepaticdysfunctionelevatedliverenzymejaundicehypoproteinemiacoagulationfunctionchangedsevere:PeriportalnecrosishepaticsubcapsularhematomahepatorrhexisHELLPsymdrome:ElevatedhepaticenzymesDecreasedbloodplatelet第11頁(yè)/共54頁(yè)CardiovascularSystemBloodPressure↑VasospasmVascularResistance↑CardiacLoad↑heartfailurevasospasmMyocardialIschemiaInterstitialEdemaSpottyNecrosispulmonaryvasospasmPulmonaryHypertensionPulmonaryEdemaOliguriawater-sodiumretentionRelativeBloodVolumeExcessIatrogenicBloodVolumeExcessHighburdenPoorability第12頁(yè)/共54頁(yè)bloodsystemRelativehypovolemiaAnemiaDecreasedbloodplateletHypercoagulabilitybloodclottingfactor↓第13頁(yè)/共54頁(yè)placenta-fetusplacenta

PlacentalhypoperfusionSpiralarteriessclerosisPlacentalInfarctionPlacentalAbruptionPlacentalfunctiondecreasesfetus

IUGRfetaldistressoligohydramniosfetaldeath第14頁(yè)/共54頁(yè)P(yáng)athophysiologyBrainHeadache;visualblurred;coma;herniaKidneyRenalfunctioncompromised;proteinuria;renalfailureLiverPersistentupperrightabdominalpain;Elevatedenzyme;jaundice;hematoma;ruptureSystematicdisease第15頁(yè)/共54頁(yè)P(yáng)athophysiologyCardiovascularsystemLowoutput-highresistance;myocardialischemia;pulmonaryhypertension;edema;heartfailureBloodLowvolume;hypercoagulability;DIC第16頁(yè)/共54頁(yè)P(yáng)athophysiologyUterusandPlacentaLowperfusion;placentalatherosclerosisPlacentalinfarction;placentalabruption;fetalgrowthretardation;fetaldeath第17頁(yè)/共54頁(yè)HighriskfactorsPrimipara<18yor>40yMultiplepregnancyHypertensionChronicnephritisMalnutritionPoorsocialstatusDiabetesAnti-phospholipidsyndromeAngiotensingeneT235(+)第18頁(yè)/共54頁(yè)EtiologyGeneticsusceptibilityhypothesisImmunemaladaptationhypothesisPlacentalischemiahypothesisOxidativestresshypothesis第19頁(yè)/共54頁(yè)

GeneticsusceptibilityImmunemaladaptationPlacentalischemiaOxidativestressAbnormalplacentalThechangeofcytokinePEdevelopmentEndotheliuminjuredDICComplications第20頁(yè)/共54頁(yè)GeneticsusceptibilityhypothesisHypertension第21頁(yè)/共54頁(yè)ImmunemaladaptationhypothesisMultiplegestationAbortionandbloodtransfusionOvumandspermdonation第22頁(yè)/共54頁(yè)P(yáng)lacentalischemiahypothesis40%totalspiralarteryareacomparedtonormalpregnancyEndothelialcellinjury第23頁(yè)/共54頁(yè)OxidativestresshypothesisOxidativestressreactionEndothelialcellinjury第24頁(yè)/共54頁(yè)CategoryandclinicalmanifestationGestationalhypertensionPreeclampsiaEclampsiaChronichypertensionPreeclampsiasuperimposedonchronichypertension第25頁(yè)/共54頁(yè)clinicalfeaturestypical:hypertension、albuminuria、edemauntypical:asymptomaticsevere:nausea、vomitheadache、dazzleconvulsion、comachestdistress、palpitation第26頁(yè)/共54頁(yè)GestationalHypertensionDefinitionHypertensionoccurs20weeksaftergestationandrecovers12weekspostpartumSBP>=140mmHgDBP>=90mmHgDiagnosedonlyafterdelivery第27頁(yè)/共54頁(yè)P(yáng)reeclampsiaHypertentionoccurs20weeksaftergestationBP>=140/90mmHgProteinuriaProteinuria≥300mg/24hUrineprotein(+)OthersymptomsHeadache,visualblurringUpperabdominalpain第28頁(yè)/共54頁(yè)SeverepreeclampsiaAtleastoneofthefollowingfeatures:CentralnervoussystemabnormalitiesHepaticsubcapsularhematoma/hepatorrhexisHepatocyteinjury:GPTBloodpressure:SBP≥160mmHg,orDBP≥110mmHgThrombocytopenia:<100109/LProteinuria:≥5g/24hor(+++)4hoursapart

Oliguria:<500ml/24hPulmonaryedemaCerebrovascularaccidentIntravascularhemolysis:anemia,jaundiceCoagulationdysfunctionFetalgrowthrestriction/oligohydramnios第29頁(yè)/共54頁(yè)

SeverepreeclampsiacomplicationsHepaticsubcapsularhematomaEarly-onsetpreeclampsia:<34wHELLPsyndrome第30頁(yè)/共54頁(yè)HELLPsyndromeHemolysisbloodsmearsshowRBCdebrisHb60-90g/LTB>20.5μmol/LElevatedserumlevelofLiverenzymesAST>70u/L,or>3SDLDH>600u/LLowPlateletsPLC<100*109/L第31頁(yè)/共54頁(yè)HELLPSeverepreeclampsia:Oneabnormalities 6%Twoabnormalities 12%Threeabnormalities 10%20gw seldomoccur1/3 occurafterdelivery80% diagnosedprenatally第32頁(yè)/共54頁(yè)HELLP——clinicaldiagnosisMightbeasymptomaticpainintherightupperabdomen 80%weightgainorsevereedema 50-60%20%cases<140/90mmHg6%caseswithoutproteinuria第33頁(yè)/共54頁(yè)SomeinvestigatiorsregardHELLPsyndromeasanentirelydistinctdiseaseentityfrompreeclampsia第34頁(yè)/共54頁(yè)ClassificationofHELLPBydegreeofthrombocytopenia:<50,000/mm350,000–100,000/mm3>100,000/mm3Notwidelyaccepted第35頁(yè)/共54頁(yè)P(yáng)athogenesisandepidemiccharacteristicsofHELLP

coremechanismendothelialinjury——intravascularcoagulationdysfunctionpredisposingfactorsthewhitemultiparaelderpregnantwomen第36頁(yè)/共54頁(yè)HELLP--mortalityMaternal0-24%hepatorrhexisDICAcuterenalfailurethrombosiscerebrovascularaccidentsPerinatal7.7-60%PrematuredeliveryIUGRplacentalabruption第37頁(yè)/共54頁(yè)Eclampsiaprocess:tonusconvulsionsleepinesscomaOccurrenceprenatalintrapartumpostpartum第38頁(yè)/共54頁(yè)ChronicHypertensionduringPregnancyHypertensionbeforepregnancyorHypertensionbefore20weeks’gestationalUnrelieved12weekspostpartumPoorfetaloutcomePerinatalmortality3timesPlacentalabruption2timesFGR,pretermbirth第39頁(yè)/共54頁(yè)preeclampsiasuperimposeduponchronichypertensionChronicHypertensionBefore20gestationalweeksPersist12weekspostpartumProteinuriaBefore20wAfter20w;withhigherBP;thrombocytopenia第40頁(yè)/共54頁(yè)DifferentialdiagnosisChronicnephritiscomplicatingpregnancyRenaldysfunctionSeizurecausedbyotherreasons第41頁(yè)/共54頁(yè)ManagementPrincipleSedationAnti-spasmAnti-hypertensionDiuresisTerminatepregnancytimely第42頁(yè)/共54頁(yè)ManagementCommontreatmentRestMonitoringOxygeninhalationDiet:saltrestrictiononlyforanasarcapatients第43頁(yè)/共54頁(yè)ManagementSedationDiazepamHibernationdrugsPethidineChlorpromazinePromethazine第44頁(yè)/共54頁(yè)ManagementAnti-spasmFirstlinetreatmentforpre-eclampsiaandeclampsiaMgSO4MechanismRegimen≥25-30g/dLoadingdose:25%MgSO410ml+10%GS20mliv5-10min25%MgSO460ml+5%GS500mlivgtt1-2g/h25%MgSO420ml+2%lidocaine2mlim.第45頁(yè)/共54頁(yè)ManagementMgSO4Treatmentconcentration1.7-3mmol/LToxicconcentration>3mmol/LToxicityMuscularparalysisPreventionandtreatmentBeforetreatmentKneereflex(+);R≥16bpm;urine≥5ml/hor600ml/24hMgconcentrationmonitoring

Ifsomethinghappens…10%calciumgluconate10mlivfordetoxificationLowerdoseorstopusewhenrenaldysfunction

第46頁(yè)/共54頁(yè)ManagementAntihypertensionIndicationSBP≥160mmHg,DBP≥110mmHg,MBP≥140mmHgPrincipleNoferaltoxicity;nolowerrenalanduterineperfusionHydralazine—firstlineLabetalol;calciumchannelblocker;methyldopaSodiumnitroprusside----onlywhenunmanageableBPACEI----contraindicatedduringpregnancy第47頁(yè)/共54頁(yè)ManagementVo

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論